Pharma companies with IBD drugs in development by number 2019
As of November 2019, both Janssen and Pfizer dominated the market and each had five IBD drugs in various phases of development. This statistic depicts selected leading pharmaceutical companies in the market of inflammatory bowel disease (IBD) treatments, by number of drugs in development.